NCT02945579: Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy |
|
|
| Recruiting | N/A | 120 | US | External Beam Radiation Therapy, Definitive Radiation Therapy, EBRT, External Beam Radiotherapy, External Beam RT, external radiation, External Radiation Therapy, external-beam radiation, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Whole Breast Irradiation | M.D. Anderson Cancer Center, National Cancer Institute (NCI) | Estrogen Receptor Negative, HER2 Positive Breast Carcinoma, HER2/Neu Negative, Invasive Breast Carcinoma, Progesterone Receptor Negative, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7, Stage II Breast Cancer AJCC v6 and v7, Stage IIA Breast Cancer AJCC v6 and v7, Stage IIB Breast Cancer AJCC v6 and v7, Triple-Negative Breast Carcinoma | 01/26 | 01/26 | | |
| Recruiting | 4 | 55 | US | coagulation factor VIIa [recombinant]-jncw, SEVENFACT | American Thrombosis and Hemostasis Network, LFB USA, Inc. | Hemophilia A With Inhibitor, Hemophilia B With Inhibitor | 11/24 | 06/25 | | |
